CliffBio
small molecule

TORECAN

THIETHYLPERAZINE MALATE

Loss of exclusivity—loss of exclusivity
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameTORECAN
Active ingredientTHIETHYLPERAZINE MALATE
Strength5MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
Marketing statusDISCN

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.